Analytics, if designed meaningfully, can empower providers, patients, families and communities. Recognizing the ability of population health analytics to support community partners and directly impact patient care, Aspenti has developed an internal population health analytics team and a versatile custom business analytic tool.
Using laboratory data alone, we can gain insights into emerging drug trends, treatment adherence and the frequency of unexpected findings. To deliver the most impactful data, Aspenti leverages our strategic partnerships to gain insights into social determinants of health and align those with emerging drug trends in a meaningful way for our providers.
Frequency Utilization Report
One of the key drivers of costs associated with urine drug testing is the frequency of testing. Our reports provide visibility into testing frequencies and are categorized based on CMS-derived local coverage determination guidance for urine drug testing. Further, we are expanding our metrics into test frequency by benchmarking against local providers, as well as stratifying by disease state (active or remission) and by time in care.
Heat Map Analytics
We have given visibility to community partners on county-level drug use demonstrating marked variability in buprenorphine adherence as well as in fentanyl and heroin use. Aspenti further partitions geospatial data into specialized catchment areas which are important to the requesting organization. By working in partnership with providers, we can define organization-specific indicators to delineate geo-boundaries for customized heatmaps. Examples include city wards, collection sites, or facilities of residence.
Patient Population Metric Report
Aspenti provides quarterly reports directly to providers to offer insights into ordering patterns and emerging drug trends. These results are benchmarked against data from other providers in the state. As requested, this report can be tailored to reflect individual clinics or organization-wide substance use patterns.